Grafa News and Videos — Page 31

Cardinal Health (NYSE:CAH) entered into a binding letter of intent with CVS Health to extend their existing pharmaceutical distribution agreement through June 30, 2032.

Agomab (NASDAQ:AGMB) reported topline results from the STENOVA open-label extension study of ontunisertib in patients with fibrostenosing Crohn’s disease, with 49 patients completing the 48-week extension period.

Origin Agritech (NASDAQ:SEED) entered into an agreement to sell its principal corn seed production subsidiary stake as part of a transaction involving Xinjiang Originbo.

Shattuck Labs (NASDAQ:STTK) announced plans to evaluate SL-325 in a Phase 2 clinical trial for patients with moderate to severe hidradenitis suppurativa (HS), expanding the program beyond its existing inflammatory bowel disease development.

CenterPoint Energy (NYSE:CNP) completed the sale of its Ohio natural gas distribution business, Vectren Energy Delivery of Ohio, to National Fuel Gas Company for $2.62 billion.

Nebius (NASDAQ:NBIS) announced the acquisition of Inferize, an inference optimization company whose technology helps reduce the time required to launch and scale large artificial intelligence models.

Commerce Bank announced the completion of its acquisition of Nolan & Associates, a St. Louis-based investment banking firm focused on serving middle-market companies nationwide.

Eli Lilly (NYSE:LLY) reported post-hoc analyses from the Phase 3 ATTAIN-1 trial showing Foundayo was associated with lower modeled 10-year risks of type 2 diabetes and cardiovascular disease in adults with obesity or overweight.

Accenture (NYSE:ACN) reported fiscal fourth-quarter revenue of $18.7 billion and full-year fiscal 2026 revenue of $74.2 billion, with full-year diluted earnings per share increasing 12% to $13.56.

McCormick (NYSE:MKC) reported third-quarter fiscal 2026 net sales growth of 17.4% and reaffirmed its full-year outlook, with adjusted earnings per share increasing to $0.86 from $0.85.